Märten, Angela <br/><br/>
A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2.  [electronic resource] 

 -  BMC cancer  May 2009 
 - 160 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/1471-2407-9-160  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Chemotherapy, Adjuvant<br/>Cisplatin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Pancreatic Neoplasms--drug therapy<br/>Prospective Studies<br/>Recombinant Proteins<br/>Young Adult